Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure

Abstract Background Hepatocyte transplantation has been proposed as an effective treatment for patients with acute liver failure (ALF), but its application is limited by a severe shortage of donor livers. Human pluripotent stem cells (hPSCs) have emerged as a potential cell source for regenerative m...

Full description

Bibliographic Details
Main Authors: Quan-Wen Liu, Qian-Yu Liu, Jing-Yuan Li, Li Wei, Kang-Kang Ren, Xiang-Cheng Zhang, Ting Ding, Ling Xiao, Wen-Jie Zhang, Han-You Wu, Hong-Bo Xin
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-018-1063-2
_version_ 1811208405788917760
author Quan-Wen Liu
Qian-Yu Liu
Jing-Yuan Li
Li Wei
Kang-Kang Ren
Xiang-Cheng Zhang
Ting Ding
Ling Xiao
Wen-Jie Zhang
Han-You Wu
Hong-Bo Xin
author_facet Quan-Wen Liu
Qian-Yu Liu
Jing-Yuan Li
Li Wei
Kang-Kang Ren
Xiang-Cheng Zhang
Ting Ding
Ling Xiao
Wen-Jie Zhang
Han-You Wu
Hong-Bo Xin
author_sort Quan-Wen Liu
collection DOAJ
description Abstract Background Hepatocyte transplantation has been proposed as an effective treatment for patients with acute liver failure (ALF), but its application is limited by a severe shortage of donor livers. Human pluripotent stem cells (hPSCs) have emerged as a potential cell source for regenerative medicine. Human amniotic epithelial stem cells (hAESCs) derived from amniotic membrane have multilineage differentiation potential which makes them suitable for possible application in hepatocyte regeneration and ALF treatment. Methods The pluripotent characteristics, immunogenicity, and tumorigenicity of hAESCs were studied by various methods. hAESCs were differentiated to hepatocyte-like cells (HLCs) using a non-transgenic and three-step induction protocol. ALB secretion, urea production, periodic acid-Schiff staining, and ICG uptake were performed to investigate the function of HLCs. The HLCs were transplanted into ALF NOD-SCID (nonobese diabetic severe combined immunodeficient) mouse, and the therapeutic effects were determined via liver function test, histopathology, and survival rate analysis. The ability of HLCs to engraft the damaged liver was evaluated by detecting the presence of GFP-positive cells. Results hAESCs expressed various markers of embryonic stem cells, epithelial stem cells, and mesenchymal stem cells and have low immunogenicity and no tumorigenicity. hAESC-derived hepatocytes possess the similar functions of human primary hepatocytes (hPH) such as producing urea, secreting ALB, uptaking ICG, storing glycogen, and expressing CYP enzymes. HLC transplantation via the tail vein could engraft in live parenchymal, improve the liver function, and protect hepatic injury from CCl4-induced ALF in mice. More importantly, HLC transplantation was able to significantly prolong the survival of ALF mouse. Conclusion We have established a rapid and efficient differentiation protocol that is able to successfully generate ample functional HLCs from hAESCs, in which the liver injuries and death rate of CCl4-induced ALF mouse can be significantly rescued by HLC transplantation. Therefore, our results may offer a superior approach for treating ALF.
first_indexed 2024-04-12T04:20:42Z
format Article
id doaj.art-06e37748eb7545e0b6268f44b03ac66b
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-04-12T04:20:42Z
publishDate 2018-11-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-06e37748eb7545e0b6268f44b03ac66b2022-12-22T03:48:15ZengBMCStem Cell Research & Therapy1757-65122018-11-019111510.1186/s13287-018-1063-2Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failureQuan-Wen Liu0Qian-Yu Liu1Jing-Yuan Li2Li Wei3Kang-Kang Ren4Xiang-Cheng Zhang5Ting Ding6Ling Xiao7Wen-Jie Zhang8Han-You Wu9Hong-Bo Xin10Institute of Translational Medicine, Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityInstitute of Translational Medicine, Nanchang UniversityAbstract Background Hepatocyte transplantation has been proposed as an effective treatment for patients with acute liver failure (ALF), but its application is limited by a severe shortage of donor livers. Human pluripotent stem cells (hPSCs) have emerged as a potential cell source for regenerative medicine. Human amniotic epithelial stem cells (hAESCs) derived from amniotic membrane have multilineage differentiation potential which makes them suitable for possible application in hepatocyte regeneration and ALF treatment. Methods The pluripotent characteristics, immunogenicity, and tumorigenicity of hAESCs were studied by various methods. hAESCs were differentiated to hepatocyte-like cells (HLCs) using a non-transgenic and three-step induction protocol. ALB secretion, urea production, periodic acid-Schiff staining, and ICG uptake were performed to investigate the function of HLCs. The HLCs were transplanted into ALF NOD-SCID (nonobese diabetic severe combined immunodeficient) mouse, and the therapeutic effects were determined via liver function test, histopathology, and survival rate analysis. The ability of HLCs to engraft the damaged liver was evaluated by detecting the presence of GFP-positive cells. Results hAESCs expressed various markers of embryonic stem cells, epithelial stem cells, and mesenchymal stem cells and have low immunogenicity and no tumorigenicity. hAESC-derived hepatocytes possess the similar functions of human primary hepatocytes (hPH) such as producing urea, secreting ALB, uptaking ICG, storing glycogen, and expressing CYP enzymes. HLC transplantation via the tail vein could engraft in live parenchymal, improve the liver function, and protect hepatic injury from CCl4-induced ALF in mice. More importantly, HLC transplantation was able to significantly prolong the survival of ALF mouse. Conclusion We have established a rapid and efficient differentiation protocol that is able to successfully generate ample functional HLCs from hAESCs, in which the liver injuries and death rate of CCl4-induced ALF mouse can be significantly rescued by HLC transplantation. Therefore, our results may offer a superior approach for treating ALF.http://link.springer.com/article/10.1186/s13287-018-1063-2Acute liver failureHuman amniotic epithelial stem cellsHepatocyte-like cellsHuman primary hepatocytesCell transplantation
spellingShingle Quan-Wen Liu
Qian-Yu Liu
Jing-Yuan Li
Li Wei
Kang-Kang Ren
Xiang-Cheng Zhang
Ting Ding
Ling Xiao
Wen-Jie Zhang
Han-You Wu
Hong-Bo Xin
Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure
Stem Cell Research & Therapy
Acute liver failure
Human amniotic epithelial stem cells
Hepatocyte-like cells
Human primary hepatocytes
Cell transplantation
title Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure
title_full Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure
title_fullStr Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure
title_full_unstemmed Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure
title_short Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure
title_sort therapeutic efficiency of human amniotic epithelial stem cell derived functional hepatocyte like cells in mice with acute hepatic failure
topic Acute liver failure
Human amniotic epithelial stem cells
Hepatocyte-like cells
Human primary hepatocytes
Cell transplantation
url http://link.springer.com/article/10.1186/s13287-018-1063-2
work_keys_str_mv AT quanwenliu therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT qianyuliu therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT jingyuanli therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT liwei therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT kangkangren therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT xiangchengzhang therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT tingding therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT lingxiao therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT wenjiezhang therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT hanyouwu therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure
AT hongboxin therapeuticefficiencyofhumanamnioticepithelialstemcellderivedfunctionalhepatocytelikecellsinmicewithacutehepaticfailure